Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-07

AUTHORS

Klaus P. Hoeflich, Juan Luo, Elizabeth A. Rubie, Ming-Sound Tsao, Ou Jin, James R. Woodgett

ABSTRACT

Glycogen synthase kinase-3 (GSK-3)-α and -β are closely related protein-serine kinases, which act as inhibitory components of Wnt signalling during embryonic development and cell proliferation in adult tissues1,2. Insight into the physiological function of GSK-3 has emerged from genetic analysis in Drosophila3,4, Dictyostelium 5 and yeast6,7. Here we show that disruption of the murine GSK-3β gene results in embryonic lethality caused by severe liver degeneration during mid-gestation, a phenotype consistent with excessive tumour necrosis factor (TNF) toxicity, as observed in mice lacking genes involved in the activation of the transcription factor activation NF-κB. GSK-3β-deficient embryos were rescued by inhibition of TNF using an anti-TNF-α antibody. Fibroblasts from GSK-3β-deficient embryos were hypersensitive to TNF-α and showed reduced NF-κB function. Lithium treatment (which inhibits GSK-3; refs 8, 9) sensitized wild-type fibroblasts to TNF and inhibited transactivation of NF-κB. The early steps leading to NF-κB activation (degradation of I-κB and translocation of NF-κB to the nucleus) were unaffected by the loss of GSK-3β, indicating that NF-κB is regulated by GSK-3β at the level of the transcriptional complex. Thus, GSK-3β facilitates NF-κB function. More... »

PAGES

86-90

Journal

TITLE

Nature

ISSUE

6791

VOLUME

406

Related Patents

  • Methods And Compositions For The Treatment Of Inflammatory Diseases
  • 3-[1-(3-Methoxypropyl )-1h-Indazol-3-Yl]-4-[1-(3-Pyridinyl )-1h-Indol-3-Yl]-1h-Pyrrole-2,5-Dione; Protein Kinase C And/Or Glycogen Synthase Kinase-3 Diseases; Diabetes, ,Alzheimer's Disease, Manic Depression, Cns Disorders; Cardiovascular, Immunological, Dermatological Disorders
  • Cardiovascular And Inflammatory Diseases; Immunological, Dermatological, Oncological And Central Nervous System Disorders; Diabetes And Associated Disorders; Protein Kinase C And Glycogen Synthase Kinase-3
  • 4-7-Dihydropyrazolo (3,4-B)Pyridine Derivative Useful As Glycogen Synthase Kinase-3 Beta (Gsk-3 Beta )- Inhibitor; Treats Diabetes, Diabetic Complications And Neurodegenerative Diseases Or As Immunopotentiators
  • Unphosphorylated Glycogen Synthase Kinase-3-G-Beta (Gsk) From Baculovirus Overexpression System; Competitive Binding; Diabetes, Alzheimer's Disease
  • Use Of Calcilytic Drugs As A Pharmacological Approach To The Treatment And Prevention Of Alzheimer's Disease, Alzheimer's Disease-Related Disorders, And Down's Syndrome Neuropathies
  • Via Detecting Elevations In Gsk3b Levels (Glycogen Synthase Kinase-4-Beta); Enzyme Inhibitors; Kits
  • Gsk-3 Inhibitors
  • Indazolyl-Substituted Pyrroline Compounds As Kinase Inhibitors
  • Combination Therapies With Mitochondrial-Targeted Anti-Tumor Agents
  • For Therapy Of Cardiovascular Diseases, Diabetes-Associated Disorders, Inflammatory Diseases, Immunological Disorders, Dermatological Disorders, Oncological And Central Nervous System Disorders; 3-[1-[3-(Dimethylamino)Propyl]-1h-Indazol-3-Yl]-4-[1-(3-Pyridinyl)-1h-Indol-3-Yl]-H-Pyrrole-2,5-Dione
  • Methods And Compositions For The Treatment Of Inflammatory Diseases
  • Unphosphorylated Glycogen Synthase Kinase-3-G-Beta (Gsk) From Baculovirus Overexpression System; Competitive Binding; Diabetes, Alzheimer's Disease
  • Pyrazolo(3,4-C)Pyridazin-3-Ylamine Derivatives; Glycogen Synthase Kinase-3 (Gsk-3); Treatment And Prevention Of Diabetes And Alzheimer's Disease
  • Inhibitors Of Gsk-3 And Crystal Structures Of Gsk-3Β Protein And Protein Complexes
  • Methods And Compositions Related To Regulation Of Cytokine Production By Glycogen Synthase Kinase 3 (Gsk-3)
  • Regulation Of Gsk-3Α Activity For The Treatment Or Prevention Of Alzheimer's Disease
  • For Therapy Of Chronic Pain, Neuropathic Pain, Epilepsy, Chronic Neurodegenerative Conditions, Dementia, Alzheimer's Disease, Schizophrenia, Manic Depression, Neurotraumatic, Cognitive Decline And Ischemia-Related Diseases
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/35017574

    DOI

    http://dx.doi.org/10.1038/35017574

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1044051571

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/10894547


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Calcium-Calmodulin-Dependent Protein Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Survival", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "E-Selectin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fetal Death", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Regulation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycogen Synthase Kinase 3", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycogen Synthase Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lithium", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Liver Diseases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred C57BL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutagenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NF-kappa B", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Necrosis Factor-alpha", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hoeflich", 
            "givenName": "Klaus P.", 
            "id": "sg:person.0620516270.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620516270.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Luo", 
            "givenName": "Juan", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rubie", 
            "givenName": "Elizabeth A.", 
            "id": "sg:person.0675466406.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675466406.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsao", 
            "givenName": "Ming-Sound", 
            "id": "sg:person.01330732406.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330732406.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jin", 
            "givenName": "Ou", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada", 
              "id": "http://www.grid.ac/institutes/grid.415224.4", 
              "name": [
                "Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Woodgett", 
            "givenName": "James R.", 
            "id": "sg:person.0731233037.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/374617a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046370946", 
              "https://doi.org/10.1038/374617a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/43474", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004390180", 
              "https://doi.org/10.1038/43474"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/362557a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005693149", 
              "https://doi.org/10.1038/362557a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/43466", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049854869", 
              "https://doi.org/10.1038/43466"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/345825a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020321842", 
              "https://doi.org/10.1038/345825a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/378785a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042289302", 
              "https://doi.org/10.1038/378785a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/376167a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032619133", 
              "https://doi.org/10.1038/376167a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2000-07", 
        "datePublishedReg": "2000-07-01", 
        "description": "Glycogen synthase kinase-3 (GSK-3)-\u03b1 and -\u03b2 are closely related protein-serine kinases, which act as inhibitory components of Wnt signalling during embryonic development and cell proliferation in adult tissues1,2. Insight into the physiological function of GSK-3 has emerged from genetic analysis in Drosophila3,4, Dictyostelium 5 and yeast6,7. Here we show that disruption of the murine GSK-3\u03b2 gene results in embryonic lethality caused by severe liver degeneration during mid-gestation, a phenotype consistent with excessive tumour necrosis factor (TNF) toxicity, as observed in mice lacking genes involved in the activation of the transcription factor activation NF-\u03baB. GSK-3\u03b2-deficient embryos were rescued by inhibition of TNF using an anti-TNF-\u03b1 antibody. Fibroblasts from GSK-3\u03b2-deficient embryos were hypersensitive to TNF-\u03b1 and showed reduced NF-\u03baB function. Lithium treatment (which inhibits GSK-3; refs  8, 9) sensitized wild-type fibroblasts to TNF and inhibited transactivation of NF-\u03baB. The early steps leading to NF-\u03baB activation (degradation of I-\u03baB and translocation of NF-\u03baB to the nucleus) were unaffected by the loss of GSK-3\u03b2, indicating that NF-\u03baB is regulated by GSK-3\u03b2 at the level of the\u00a0transcriptional complex. Thus, GSK-3\u03b2 facilitates NF-\u03baB function.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/35017574", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6791", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "406"
          }
        ], 
        "keywords": [
          "NF-\u03baB function", 
          "deficient embryos", 
          "GSK-3\u03b2", 
          "glycogen synthase kinase-3", 
          "protein-serine kinase", 
          "synthase kinase-3", 
          "glycogen synthase kinase-3\u03b2", 
          "wild-type fibroblasts", 
          "NF-\u03baB activation", 
          "synthase kinase-3\u03b2", 
          "embryonic lethality", 
          "transcriptional complex", 
          "embryonic development", 
          "transactivation of NF", 
          "genetic analysis", 
          "gene results", 
          "kinase 3", 
          "GSK-3", 
          "physiological functions", 
          "cell survival", 
          "kinase-3\u03b2", 
          "early steps", 
          "cell proliferation", 
          "embryos", 
          "tumor necrosis factor toxicity", 
          "severe liver degeneration", 
          "NF-\u03baB", 
          "activation", 
          "liver degeneration", 
          "fibroblasts", 
          "transactivation", 
          "kinase", 
          "inhibition of TNF", 
          "Wnt", 
          "genes", 
          "phenotype", 
          "lethality", 
          "GSK", 
          "NF", 
          "function", 
          "proliferation", 
          "TNF", 
          "inhibitory component", 
          "complexes", 
          "TNF-\u03b1 antibody", 
          "disruption", 
          "inhibition", 
          "insights", 
          "mice", 
          "survival", 
          "toxicity", 
          "antibodies", 
          "loss", 
          "development", 
          "components", 
          "levels", 
          "degeneration", 
          "lithium treatment", 
          "step", 
          "analysis", 
          "results", 
          "treatment", 
          "adults", 
          "requirements"
        ], 
        "name": "Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation", 
        "pagination": "86-90", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1044051571"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/35017574"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "10894547"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/35017574", 
          "https://app.dimensions.ai/details/publication/pub.1044051571"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:49", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_328.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/35017574"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/35017574'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/35017574'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/35017574'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/35017574'


     

    This table displays all metadata directly associated to this object as RDF triples.

    274 TRIPLES      21 PREDICATES      119 URIs      103 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/35017574 schema:about N0275b44ecb5447578e36f8c3b9442990
    2 N0a269add6fa44be3becdfa82e5635922
    3 N13207c307b2a44a2822c9017384fd721
    4 N20d35f79793a472bb395fffef6489ff8
    5 N432e3376c3b443b288dca54e1eae9659
    6 N44d70b94d7524f8d910ed38a0490e31b
    7 N66d1c631a2564d1ab77cd8fde9b84947
    8 N7a7a5f662496415a99462c28db374166
    9 N90ace1457fa64a5d9d5ba40adb4d6f45
    10 N9af053de7a6f4316b957b2572dae39f7
    11 N9ecbebc7fa554fcc8e0af9bfeac99684
    12 Na34a3a1afc4b4506b7f90312387805a7
    13 Na45a2e21dbee4599a1c1f4cbd6ca123d
    14 Nb549449cbb1b46949c4beebcb182b9cc
    15 Nc1b9c7c484e7497eb39874181fe0d067
    16 Nc2fd54fa6ad34b789c8ff7a030e7c5ec
    17 Ncb35c4f7ac714056b9749fda722c28fa
    18 Nd12c1f676d634ae8818fc8bbfdd9b408
    19 Nd6ee6412d373465c8107d8056a682884
    20 Nd96e081eb18a44b5bc8be881ea40ba21
    21 Nfdc2bd26f32f4069ad254a0e3755b6df
    22 anzsrc-for:06
    23 anzsrc-for:0601
    24 anzsrc-for:0604
    25 schema:author N9516cbcea2d341b2843d80c878b410a6
    26 schema:citation sg:pub.10.1038/345825a0
    27 sg:pub.10.1038/362557a0
    28 sg:pub.10.1038/374617a0
    29 sg:pub.10.1038/376167a0
    30 sg:pub.10.1038/378785a0
    31 sg:pub.10.1038/43466
    32 sg:pub.10.1038/43474
    33 schema:datePublished 2000-07
    34 schema:datePublishedReg 2000-07-01
    35 schema:description Glycogen synthase kinase-3 (GSK-3)-α and -β are closely related protein-serine kinases, which act as inhibitory components of Wnt signalling during embryonic development and cell proliferation in adult tissues1,2. Insight into the physiological function of GSK-3 has emerged from genetic analysis in Drosophila3,4, Dictyostelium 5 and yeast6,7. Here we show that disruption of the murine GSK-3β gene results in embryonic lethality caused by severe liver degeneration during mid-gestation, a phenotype consistent with excessive tumour necrosis factor (TNF) toxicity, as observed in mice lacking genes involved in the activation of the transcription factor activation NF-κB. GSK-3β-deficient embryos were rescued by inhibition of TNF using an anti-TNF-α antibody. Fibroblasts from GSK-3β-deficient embryos were hypersensitive to TNF-α and showed reduced NF-κB function. Lithium treatment (which inhibits GSK-3; refs 8, 9) sensitized wild-type fibroblasts to TNF and inhibited transactivation of NF-κB. The early steps leading to NF-κB activation (degradation of I-κB and translocation of NF-κB to the nucleus) were unaffected by the loss of GSK-3β, indicating that NF-κB is regulated by GSK-3β at the level of the transcriptional complex. Thus, GSK-3β facilitates NF-κB function.
    36 schema:genre article
    37 schema:isAccessibleForFree false
    38 schema:isPartOf N2068511adadd44a6afb5d798a0140ca6
    39 N470329a3b5944181891ad5ce0ee7fa20
    40 sg:journal.1018957
    41 schema:keywords GSK
    42 GSK-3
    43 GSK-3β
    44 NF
    45 NF-κB
    46 NF-κB activation
    47 NF-κB function
    48 TNF
    49 TNF-α antibody
    50 Wnt
    51 activation
    52 adults
    53 analysis
    54 antibodies
    55 cell proliferation
    56 cell survival
    57 complexes
    58 components
    59 deficient embryos
    60 degeneration
    61 development
    62 disruption
    63 early steps
    64 embryonic development
    65 embryonic lethality
    66 embryos
    67 fibroblasts
    68 function
    69 gene results
    70 genes
    71 genetic analysis
    72 glycogen synthase kinase-3
    73 glycogen synthase kinase-3β
    74 inhibition
    75 inhibition of TNF
    76 inhibitory component
    77 insights
    78 kinase
    79 kinase 3
    80 kinase-3β
    81 lethality
    82 levels
    83 lithium treatment
    84 liver degeneration
    85 loss
    86 mice
    87 phenotype
    88 physiological functions
    89 proliferation
    90 protein-serine kinase
    91 requirements
    92 results
    93 severe liver degeneration
    94 step
    95 survival
    96 synthase kinase-3
    97 synthase kinase-3β
    98 toxicity
    99 transactivation
    100 transactivation of NF
    101 transcriptional complex
    102 treatment
    103 tumor necrosis factor toxicity
    104 wild-type fibroblasts
    105 schema:name Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
    106 schema:pagination 86-90
    107 schema:productId N0f5c56bfd4564328afe5c63a1ed7e87b
    108 Naf7cd04ac1a949358cb1b4566fab62ab
    109 Nbf2b235463d04781af6d41219bd350b2
    110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044051571
    111 https://doi.org/10.1038/35017574
    112 schema:sdDatePublished 2022-09-02T15:49
    113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    114 schema:sdPublisher Nf3459aef3ffd4048812d8a6abe5b0a46
    115 schema:url https://doi.org/10.1038/35017574
    116 sgo:license sg:explorer/license/
    117 sgo:sdDataset articles
    118 rdf:type schema:ScholarlyArticle
    119 N0275b44ecb5447578e36f8c3b9442990 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Transcription, Genetic
    121 rdf:type schema:DefinedTerm
    122 N0a269add6fa44be3becdfa82e5635922 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Calcium-Calmodulin-Dependent Protein Kinases
    124 rdf:type schema:DefinedTerm
    125 N0f5c56bfd4564328afe5c63a1ed7e87b schema:name pubmed_id
    126 schema:value 10894547
    127 rdf:type schema:PropertyValue
    128 N13207c307b2a44a2822c9017384fd721 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Lithium
    130 rdf:type schema:DefinedTerm
    131 N2068511adadd44a6afb5d798a0140ca6 schema:volumeNumber 406
    132 rdf:type schema:PublicationVolume
    133 N20d35f79793a472bb395fffef6489ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Tumor Necrosis Factor-alpha
    135 rdf:type schema:DefinedTerm
    136 N3dca6ef043da4e3aa4e8c278c6c9feb3 rdf:first sg:person.0731233037.88
    137 rdf:rest rdf:nil
    138 N432e3376c3b443b288dca54e1eae9659 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name E-Selectin
    140 rdf:type schema:DefinedTerm
    141 N44d70b94d7524f8d910ed38a0490e31b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Liver Diseases
    143 rdf:type schema:DefinedTerm
    144 N470329a3b5944181891ad5ce0ee7fa20 schema:issueNumber 6791
    145 rdf:type schema:PublicationIssue
    146 N66d1c631a2564d1ab77cd8fde9b84947 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Cell Survival
    148 rdf:type schema:DefinedTerm
    149 N71fc35f9da8c4d3cbff85076b5baa3d5 rdf:first sg:person.01330732406.82
    150 rdf:rest Nd67633a74bcc4171b5b57c9873a42af8
    151 N75b4a893dd59437698320b98967c5a3e rdf:first sg:person.0675466406.79
    152 rdf:rest N71fc35f9da8c4d3cbff85076b5baa3d5
    153 N77d9d1dbb1ea4dc7bc0ef8ebc5158231 schema:affiliation grid-institutes:grid.415224.4
    154 schema:familyName Jin
    155 schema:givenName Ou
    156 rdf:type schema:Person
    157 N7a7a5f662496415a99462c28db374166 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Glycogen Synthase Kinases
    159 rdf:type schema:DefinedTerm
    160 N7bc270f6f28843ab8250f7992b8f26d9 schema:affiliation grid-institutes:grid.415224.4
    161 schema:familyName Luo
    162 schema:givenName Juan
    163 rdf:type schema:Person
    164 N90ace1457fa64a5d9d5ba40adb4d6f45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name NF-kappa B
    166 rdf:type schema:DefinedTerm
    167 N9516cbcea2d341b2843d80c878b410a6 rdf:first sg:person.0620516270.10
    168 rdf:rest Nfbbd1a8a342044479b1b2634bca2c459
    169 N9af053de7a6f4316b957b2572dae39f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Enzyme Inhibitors
    171 rdf:type schema:DefinedTerm
    172 N9ecbebc7fa554fcc8e0af9bfeac99684 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Mice, Inbred C57BL
    174 rdf:type schema:DefinedTerm
    175 Na34a3a1afc4b4506b7f90312387805a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Apoptosis
    177 rdf:type schema:DefinedTerm
    178 Na45a2e21dbee4599a1c1f4cbd6ca123d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Cell Line
    180 rdf:type schema:DefinedTerm
    181 Naf7cd04ac1a949358cb1b4566fab62ab schema:name doi
    182 schema:value 10.1038/35017574
    183 rdf:type schema:PropertyValue
    184 Nb549449cbb1b46949c4beebcb182b9cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Glycogen Synthase Kinase 3
    186 rdf:type schema:DefinedTerm
    187 Nbf2b235463d04781af6d41219bd350b2 schema:name dimensions_id
    188 schema:value pub.1044051571
    189 rdf:type schema:PropertyValue
    190 Nc1b9c7c484e7497eb39874181fe0d067 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Mutagenesis
    192 rdf:type schema:DefinedTerm
    193 Nc2fd54fa6ad34b789c8ff7a030e7c5ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Gene Expression Regulation
    195 rdf:type schema:DefinedTerm
    196 Ncb35c4f7ac714056b9749fda722c28fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Mice
    198 rdf:type schema:DefinedTerm
    199 Nd12c1f676d634ae8818fc8bbfdd9b408 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Fetal Death
    201 rdf:type schema:DefinedTerm
    202 Nd67633a74bcc4171b5b57c9873a42af8 rdf:first N77d9d1dbb1ea4dc7bc0ef8ebc5158231
    203 rdf:rest N3dca6ef043da4e3aa4e8c278c6c9feb3
    204 Nd6ee6412d373465c8107d8056a682884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Male
    206 rdf:type schema:DefinedTerm
    207 Nd96e081eb18a44b5bc8be881ea40ba21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Animals
    209 rdf:type schema:DefinedTerm
    210 Nf3459aef3ffd4048812d8a6abe5b0a46 schema:name Springer Nature - SN SciGraph project
    211 rdf:type schema:Organization
    212 Nfbbd1a8a342044479b1b2634bca2c459 rdf:first N7bc270f6f28843ab8250f7992b8f26d9
    213 rdf:rest N75b4a893dd59437698320b98967c5a3e
    214 Nfdc2bd26f32f4069ad254a0e3755b6df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Female
    216 rdf:type schema:DefinedTerm
    217 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    218 schema:name Biological Sciences
    219 rdf:type schema:DefinedTerm
    220 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    221 schema:name Biochemistry and Cell Biology
    222 rdf:type schema:DefinedTerm
    223 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    224 schema:name Genetics
    225 rdf:type schema:DefinedTerm
    226 sg:journal.1018957 schema:issn 0028-0836
    227 1476-4687
    228 schema:name Nature
    229 schema:publisher Springer Nature
    230 rdf:type schema:Periodical
    231 sg:person.01330732406.82 schema:affiliation grid-institutes:grid.415224.4
    232 schema:familyName Tsao
    233 schema:givenName Ming-Sound
    234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330732406.82
    235 rdf:type schema:Person
    236 sg:person.0620516270.10 schema:affiliation grid-institutes:grid.415224.4
    237 schema:familyName Hoeflich
    238 schema:givenName Klaus P.
    239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620516270.10
    240 rdf:type schema:Person
    241 sg:person.0675466406.79 schema:affiliation grid-institutes:grid.415224.4
    242 schema:familyName Rubie
    243 schema:givenName Elizabeth A.
    244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675466406.79
    245 rdf:type schema:Person
    246 sg:person.0731233037.88 schema:affiliation grid-institutes:grid.415224.4
    247 schema:familyName Woodgett
    248 schema:givenName James R.
    249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88
    250 rdf:type schema:Person
    251 sg:pub.10.1038/345825a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020321842
    252 https://doi.org/10.1038/345825a0
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/362557a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005693149
    255 https://doi.org/10.1038/362557a0
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/374617a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046370946
    258 https://doi.org/10.1038/374617a0
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1038/376167a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032619133
    261 https://doi.org/10.1038/376167a0
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1038/378785a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042289302
    264 https://doi.org/10.1038/378785a0
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/43466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049854869
    267 https://doi.org/10.1038/43466
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/43474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004390180
    270 https://doi.org/10.1038/43474
    271 rdf:type schema:CreativeWork
    272 grid-institutes:grid.415224.4 schema:alternateName Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada
    273 schema:name Ontario Cancer Institute/Princess Margaret Hospital, 610 University Avenue, M5G 2M9, Toronto, Ontario, Canada
    274 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...